SCHEMBL22015632

SCHEMBL22015632

OCCOCCOCCOCCOc1ccc(-c2nc3ccccc3s2)cc1OC(F)(F)F

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.49
KDM4E B2RXH2 5/20 0.49
NPC1 O15118 4/20 0.49
KMT2A Q03164 3/20 0.49
GLA P06280 3/20 0.49
SMN1; SMN2 Q16637 4/20 0.47
ALDH1A1 P00352 4/20 0.47
RAB9A P51151 4/20 0.47
TP53 P04637 4/20 0.47
HPGD P15428 2/20 0.47
MEN1 O00255 2/20 0.47
HSD17B10 Q99714 2/20 0.47
GAA P10253 2/20 0.47
BLM P54132 2/20 0.47
PPARG P37231 1/20 0.47
NCOA2 Q15596 1/20 0.47
NCOA1 Q15788 1/20 0.47
HCRTR1 O43613 1/20 0.47
MAPK1 P28482 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22015767 0.87 KDM4E (0.47) MAPTKDM4ENPC1KMT2AGLA
SCHEMBL22015459 0.86 MAPT (0.51) MAPTKDM4ENPC1KMT2AGLA
SCHEMBL25713690 0.84 KDM4E (0.51) MAPTKDM4ENPC1KMT2AGLA
SCHEMBL22015635 0.84 MAPT (0.52) MAPTKDM4ENPC1KMT2AGLA
SCHEMBL22015453 0.83 MAPT (0.50) MAPTKDM4ENPC1KMT2AGLA
SCHEMBL22015466 0.83 APP (0.53) MAPTKDM4ENPC1KMT2AGLA
SCHEMBL22015638 0.83 PTGS1 (0.54) MAPTKDM4ENPC1KMT2AGLA
SCHEMBL22015994 0.83 MAPT (0.53) MAPTKDM4ENPC1KMT2AGLA
SCHEMBL22015837 0.81 KDM4E (0.48) MAPTKDM4ENPC1KMT2AGLA
SCHEMBL22015996 0.81 SMN1; SMN2 (0.51) MAPTKDM4ENPC1KMT2AGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220017477-A1 BENZOTHIAZOLE AND RELATED COMPOUNDS SPINOGENIX, INC. 2022-01-20 US disclosed
US-11117878-B2 Benzothiazole and related compounds SPINOGENIX, INC. (US) 2021-09-14 US disclosed
US-20200157068-A1 BENZOTHIAZOLE AND RELATED COMPOUNDS SPINOGENIX, INC. 2020-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220017477-A1 BENZOTHIAZOLE AND RELATED COMPOUNDS BACE1, APP, BACE2 MAPT 5/4885KDM4E 3807/4885NPC1 1283/4885
US-11117878-B2 Benzothiazole and related compounds BACE1, APP, BACE2 MAPT 5/4885KDM4E 3807/4885NPC1 1283/4885
US-20200157068-A1 BENZOTHIAZOLE AND RELATED COMPOUNDS BACE1, APP, BACE2 MAPT 5/4885KDM4E 3807/4885NPC1 1283/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.